Does Bacitracin Help Wounds Heal Faster?

Bacitracin does not make wounds heal faster. Randomized controlled trials comparing bacitracin ointment to plain petrolatum (the greasy base the antibiotic is mixed into) have found no clinically significant difference in healing speed at any time point measured. The ointment’s real contribution to a minor cut or scrape comes from the petroleum jelly it rides in, which keeps the wound moist, not from the antibiotic itself. That distinction matters, because bacitracin carries risks that plain petrolatum does not.

What the Trials Actually Found

The most direct test of whether bacitracin speeds healing came from a randomized trial published in JAMA that compared white petrolatum to bacitracin ointment in patients who had just undergone outpatient skin surgery. The researchers assessed wounds at days one, seven, and twenty-eight and found no clinically significant differences in healing between the two groups at any of those checkpoints.¹ In other words, the antibiotic added nothing measurable to recovery.

A separate study using a laser wound model to compare several common over-the-counter wound treatments reinforced the same conclusion from a different angle. Wounds treated with a non-antibiotic healing ointment (an aquaphor-based formula) showed better outcomes in redness, swelling, and skin regrowth compared to both bacitracin-polymyxin and the triple-antibiotic combination of polymyxin-bacitracin-neomycin. The two antibiotic-containing products performed identically to each other, while the antibiotic-free product outperformed both.² When subjects were asked to rank their treated sites, they too preferred the non-antibiotic ointment.

Yet another head-to-head comparison of an aquaphor-based ointment against a polymyxin-bacitracin combination found no differences in redness, swelling, skin regrowth, crusting, or scabbing at any time point.³ The pattern across these studies is consistent: bacitracin performs no better than, and sometimes worse than, an inert moisturizing barrier.

Why the Grease Matters More Than the Antibiotic

Wound healing depends on a moist environment. When a wound dries out and forms a hard scab, new skin cells have to burrow underneath the crust to close the gap, which is slower and more prone to scarring. A layer of petrolatum prevents that drying, letting new cells migrate across a smooth, hydrated surface. Any ointment-based product, whether it contains an antibiotic or not, provides this benefit simply because of its greasy base.

Research going back decades has shown that the vehicle (the base cream or ointment a drug is mixed into) can account for a surprisingly large share of the healing effect attributed to a topical product. One early study on wound re-epithelialization found that a vehicle cream by itself sped up skin regrowth by about a fifth, and the active antimicrobial ingredient on top of it added only a modest additional increment that could not be explained by antibacterial action alone.⁴ The moisture, occlusion, and physical protection of the ointment base were doing most of the heavy lifting.

This helps explain why plain petrolatum keeps matching bacitracin in trial after trial. You are already getting the main healing benefit from the petroleum jelly. The bacitracin is along for the ride.

Infection Prevention Is a Separate Question

Some people reach for bacitracin not because they expect faster healing, but because they want to prevent infection. That is a different question, and the answer is more nuanced, but still not strongly in bacitracin’s favor for everyday cuts and scrapes.

The JAMA trial that compared petrolatum to bacitracin also tracked infection rates. Clean surgical wounds had very low infection rates in both groups. For minor wounds that are cleaned properly and kept covered, the risk of infection is already small, and bacitracin does not meaningfully reduce it further in that setting. Petrolatum itself offers a physical barrier that keeps bacteria and debris out of a wound, which accounts for much of the protective effect people attribute to the antibiotic.

In a pilot trial comparing triple-antibiotic ointment (which contains bacitracin along with polymyxin and neomycin) to mupirocin for uncomplicated soft tissue wounds, the triple-antibiotic group had a slightly lower rate of infection signs, but the difference was not statistically significant.⁵ Both groups reported similar compliance with wound care and dressing changes. The takeaway is that for minor wounds, diligent cleaning and covering matters at least as much as which ointment you smear on top.

Allergic Reactions and Rarer Dangers

Bacitracin is not as benign as its ubiquity on pharmacy shelves might suggest. Allergic contact dermatitis, a red, itchy rash that develops around the wound site, is a recognized complication. In one study of surgery patients using topical antibiotics, about two percent of those who used bacitracin-containing products developed patch-test-confirmed allergic contact dermatitis.⁶ The rash can easily be mistaken for a wound infection, which sometimes leads to an unnecessary course of oral antibiotics, compounding the problem.

More alarming, though rare, is the possibility of anaphylaxis. A case report described a young man who went into severe anaphylactic shock within five minutes of having bacitracin zinc ointment applied to a wound. He required epinephrine, antihistamines, IV fluids, and corticosteroids. Skin prick testing confirmed bacitracin as the trigger.⁷ Cases like this are uncommon, but they underscore that “over-the-counter” does not mean “risk-free.” Anyone who has had a previous allergic reaction to bacitracin, or who develops unusual swelling, hives, or breathing difficulty after applying it, should stop using it immediately.

The Resistance Concern

Antibiotic resistance is typically framed as a problem of oral and intravenous drugs, but topical antibiotics contribute too. Researchers testing methicillin-resistant Staphylococcus aureus (MRSA) isolates found that the USA300 strain, the most common community-associated MRSA clone in the United States, was resistant to both bacitracin and neomycin, the two active ingredients in over-the-counter antibiotic ointments. No other strain in their collection of over 250 isolates showed that dual resistance pattern.⁸ The authors raised the possibility that widespread over-the-counter antibiotic use could be selecting for this particular strain.

Separately, research on the skin microbiome has shown that topical antibiotics cause immediate and lasting shifts in the bacteria living on the skin surface. These shifts persisted for multiple days after treatment ended. Antiseptics like chlorhexidine, by comparison, caused only minor changes to the underlying bacterial community.⁹ Both antibiotics and antiseptics reduced colonization by commensal Staphylococcus species, but the antibiotic effect was more disruptive overall. When you kill off the friendly bacteria that normally compete with pathogens for territory on your skin, you can inadvertently open the door for more dangerous organisms to move in.

For a minor kitchen cut, the contribution of one tube of bacitracin to the global resistance crisis is admittedly tiny. But the cumulative effect of millions of people routinely applying an antibiotic they do not need adds up, and it is one of the easier exposures to eliminate because a non-antibiotic alternative works just as well.

The Cytotoxicity Problem

There is another layer to the story that most people never hear about. Many topical antimicrobials, bacitracin included, are directly toxic to the very cells responsible for wound repair. Laboratory studies have shown that commonly used topical agents reduce the activity of fibroblasts (the cells that produce new connective tissue) and keratinocytes (the cells that form the outer layer of skin) at concentrations routinely applied in clinical settings.¹⁰ This does not mean bacitracin is poisoning your wound every time you use it; the real-world effect depends on concentration, how much ointment is applied, and the wound’s depth. But it does suggest that slathering on antibiotic ointment “just to be safe” could, at some level, be counterproductive to healing rather than neutral.

Why Doctors Still Recommend It

If the evidence is this clear, why does your post-surgery discharge sheet still tell you to apply bacitracin? Habit, mostly. A study that surveyed wound care instructions from nearly 300 non-dermatology clinics found that about 60 percent of the instructions recommended a topical antibiotic such as bacitracin or a polymyxin-neomycin combination. Surgical specialties were even more likely to recommend them, at roughly 74 percent, compared to about 43 percent in primary care.¹¹ This persists despite guidelines from dermatology organizations recommending plain petroleum jelly for clean surgical wounds.

Dermatologists, who deal with wound healing as a core part of their specialty, were the group least likely to recommend topical antibiotics. The gap between dermatology practice and everyone else’s wound care handouts is striking. Part of the issue is that wound care instructions at many clinics have not been updated in years. Another factor is patient expectation: people feel like they are doing something active for their wound when they apply a product labeled as an antibiotic, and doctors know that feeling of agency improves compliance with basic wound care.

What to Use Instead

For a minor cut, scrape, or burn, the evidence-supported approach is straightforward:

Clean the wound: Rinse with clean running water. Soap around (not directly in) the wound is fine. You do not need hydrogen peroxide or rubbing alcohol, both of which damage healthy tissue.
Apply plain petrolatum: A thin layer of petroleum jelly keeps the wound moist and creates a barrier against bacteria. This is the same benefit bacitracin ointment provides, without the antibiotic, the allergy risk, or the resistance concern.
Cover with a bandage: A simple adhesive bandage or gauze pad, changed daily or when it gets wet or dirty, is sufficient for most minor wounds.

For people who want something a step up from petrolatum and a basic bandage, hydrocolloid dressings are worth knowing about. These self-adhesive patches, originally developed for chronic wounds like pressure ulcers, have been shown to decrease healing times of acute wounds by a substantial margin compared to traditional dry dressings. One review found that donor-site wounds (where skin is harvested for grafts, a standardized wound model) healed roughly 40 percent faster under hydrocolloid dressings.¹² These dressings maintain moisture, absorb excess fluid, and protect the wound from friction, all without any antibiotic component. They are widely available at pharmacies, usually marketed as “blister bandages” or “hydrocolloid patches.”

When Bacitracin Might Still Make Sense

There are situations where a topical antibiotic is genuinely appropriate, even if it does not speed healing per se. Contaminated wounds, such as animal bites, deep punctures, or injuries sustained in dirty environments, carry a higher baseline infection risk than a clean kitchen nick. In those cases, a doctor might prescribe a topical or oral antibiotic based on the specific contamination risk, and the choice would likely be something more targeted than over-the-counter bacitracin anyway.

People with diabetes, compromised immune systems, or poor circulation in their extremities face higher wound-infection risks and slower healing overall. For these groups, wound care decisions should involve a clinician rather than the pharmacy first-aid aisle. The evidence that bacitracin outperforms petrolatum was generated in healthy populations with clean surgical wounds, so extrapolating to high-risk patients is not straightforward.

If you already have bacitracin in your medicine cabinet and have used it without problems, there is no urgent reason to throw it away. The risks are real but small for any individual. The point is that you are not gaining a healing advantage by using it, so if your goal is faster recovery, your energy is better spent on keeping the wound moist, covered, and clean.

How Bacitracin Became a Medicine Cabinet Staple

Bacitracin’s origin story is unusually specific for an antibiotic. It was first discovered in 1943, isolated from a Bacillus strain cultured from the leg wound of a seven-year-old girl named Margaret Tracey. The antibiotic’s name is literally a mashup of “Bacillus” and “Tracey.”¹³ It works by blocking a step in bacterial cell wall construction, which makes it effective against many Gram-positive bacteria on contact.

The reason bacitracin ended up as an over-the-counter product rather than a prescription drug is that it is barely absorbed through the skin. Applied topically to minor wounds, it stays local. The FDA classified it, along with polymyxin B and neomycin, as generally recognized as safe and effective for over-the-counter use on minor cuts, scrapes, and burns. That regulatory status, combined with decades of marketing and a low price point, cemented bacitracin’s place in nearly every household first-aid kit in the country. Its reputation as essential wound care was built more by familiarity and availability than by clinical evidence that it outperforms simpler alternatives. The science has quietly moved on, even if the pharmacy aisle has not caught up.